These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


191 related items for PubMed ID: 7879205

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peripheral blood monitoring during and after rejection-prophylaxis with a monoclonal anti-interleukin-2-receptor antibody in kidney and heart transplant recipients.
    van Gelder T, Knoop CJ, Hesse CJ, Vaessen LM, Balk AH, Yzermans JN, Weimar W.
    Transplant Proc; 1995 Feb; 27(1):856-8. PubMed ID: 7879206
    [No Abstract] [Full Text] [Related]

  • 3. Successful treatment of renal allograft rejection with a humanized antilymphocyte monoclonal antibody.
    Friend PJ, Rebello P, Oliveira D, Manna V, Cobbold SP, Hale G, Jamieson NV, Jamieson I, Calne RY, Harris DT.
    Transplant Proc; 1995 Feb; 27(1):869-70. PubMed ID: 7879212
    [No Abstract] [Full Text] [Related]

  • 4. CD4 and CD25 monoclonal antibody cocktail in kidney transplant rejection prophylaxis: clinical results of a pilot study.
    Mousson C, Tanter Y, Racadot E, Wijdenes J, Chalopin JM, Chevet D, Hervé P, Rifle G.
    Transplant Proc; 1995 Apr; 27(2):1727-8. PubMed ID: 7725472
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. [Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].
    Carl S, Wiesel M, Deiss JM, Daniel V, Opelz G, Staehler G.
    J Urol (Paris); 1997 Apr; 103(1-2):7-9. PubMed ID: 9765770
    [No Abstract] [Full Text] [Related]

  • 7. Phenotypic and functional analysis of graft-infiltrating cells following therapy with anti-interleukin-2 receptor monoclonal antibody and cyclosporine A in the rat.
    Sido B, Morris PJ, Dallman M.
    Transplant Proc; 1992 Dec; 24(6):2549-50. PubMed ID: 1465862
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Immunosuppression in small bowel transplantation--treatment with a monoclonal IL-2 receptor antibody (NDS 61).
    Schweizer E, Papachrysanthou A, Faendrich F, Deltz E, Schroeder P.
    Transplant Proc; 1994 Dec; 26(6):3142-3. PubMed ID: 7998095
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Plasma exchange vs cyclosporine retrieval therapy in steroid-resistant acute rejection of renal allografts.
    Dikshit MP, Acharya VN, Trivedi HS, Almeida AF.
    Transplant Proc; 1992 Oct; 24(5):1724. PubMed ID: 1412811
    [No Abstract] [Full Text] [Related]

  • 19. Anti-CD4 monoclonal antibody therapy of late acute rejection in renal allograft recipients--CD4+ T cells play an essential role in the rejection process.
    Reinke P, Kern F, Fietze E, Döcke WD, Ewert R, Emmrich F, Volk HD.
    Transplant Proc; 1995 Feb; 27(1):859-62. PubMed ID: 7879207
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 10.